Variant report

Variant	esv3403106
Chromosome Location	chr6:28770790-28785189
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:37)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:37 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:28692413..28694711-chr6:28778373..28780345,2	K562	blood:
2	chr6:28778307..28780155-chr6:28804697..28807128,2	K562	blood:
3	chr6:28688964..28691307-chr6:28783200..28785150,2	K562	blood:
4	chr6:28767356..28769263-chr6:28782865..28784537,2	K562	blood:
5	chr6:27112538..27114831-chr6:28781719..28783622,2	K562	blood:
6	chr6:28722382..28724843-chr6:28784005..28786428,2	K562	blood:
7	chr6:28756573..28759569-chr6:28769791..28772080,4	K562	blood:
8	chr6:28771461..28773672-chr6:28829844..28832711,2	K562	blood:
9	chr6:28769803..28772263-chr6:28862688..28865946,3	MCF-7	breast:
10	chr6:28653637..28654159-chr6:28777644..28778612,2	MCF-7	breast:
11	chr6:28737526..28738316-chr6:28777463..28778342,2	K562	blood:
12	chr6:28687325..28688855-chr6:28783516..28785419,2	K562	blood:
13	chr6:28723977..28727923-chr6:28779903..28783132,3	K562	blood:
14	chr6:28687938..28689790-chr6:28777726..28779382,2	K562	blood:
15	chr6:28777118..28779341-chr6:28889220..28890745,2	MCF-7	breast:
16	chr6:28722382..28725655-chr6:28783034..28786428,3	K562	blood:
17	chr6:28772556..28774593-chr6:28785044..28786627,2	K562	blood:
18	chr6:28771451..28773263-chr6:28777101..28779175,2	K562	blood:
19	chr6:28760359..28762539-chr6:28774291..28776179,2	K562	blood:
20	chr6:28187117..28189206-chr6:28783315..28785702,2	K562	blood:
21	chr6:28771451..28773263-chr6:28777101..28779175,2	K562	blood:
22	chr6:28768996..28771268-chr6:28774440..28778213,3	K562	blood:
23	chr6:28783316..28785641-chr6:28791797..28793442,2	K562	blood:
24	chr6:28772556..28774593-chr6:28785044..28786627,2	K562	blood:
25	chr6:28775179..28778043-chr6:28889400..28891921,3	MCF-7	breast:
26	chr6:28774872..28779186-chr6:28780865..28786550,9	K562	blood:
27	chr6:28770520..28773672-chr6:28829844..28832870,3	K562	blood:
28	chr6:28769403..28772112-chr6:28910261..28912768,2	K562	blood:
29	chr6:28770558..28773254-chr6:28806737..28808772,2	K562	blood:
30	chr6:28774860..28778003-chr6:28805367..28807894,3	K562	blood:
31	chr6:28739213..28740105-chr6:28777494..28778016,2	K562	blood:
32	chr6:28768996..28771268-chr6:28774440..28778213,3	K562	blood:
33	chr6:28760359..28764219-chr6:28771578..28776179,5	K562	blood:
34	chr6:28746343..28748629-chr6:28776362..28778668,2	K562	blood:
35	chr6:28779162..28781130-chr6:28862892..28865549,2	K562	blood:
36	chr6:28774872..28779186-chr6:28780865..28786550,9	K562	blood:
37	chr6:28723125..28726078-chr6:28775767..28777359,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TRIM27-18	chr6:28773744-28776603	NONHSAT108486

No data

Variant related genes	Relation type
ENSG00000265764	chromatin interactions
ENSG00000224157	chromatin interactions
ENSG00000197903	chromatin interactions
ENSG00000225173	chromatin interactions
ENSG00000204709	chromatin interactions
ENSG00000204713	chromatin interactions
ENSG00000225595	chromatin interactions

Extended variants
information (count: 545 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:545 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs373615194	chr6:28770814-28770815	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs371280361	chr6:28770846-28770847	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs112105273	chr6:28770881-28770882	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs7763940	chr6:28770908-28770909	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs190178544	chr6:28770972-28770973	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs547496509	chr6:28771006-28771007	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs569122777	chr6:28771037-28771038	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs143080775	chr6:28771095-28771096	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs554369587	chr6:28771099-28771100	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs574370942	chr6:28771112-28771113	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs533593028	chr6:28771114-28771115	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs554020868	chr6:28771138-28771139	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs182812909	chr6:28771181-28771182	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs2013652	chr6:28771198-28771199	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs2013649	chr6:28771231-28771232	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs576315690	chr6:28771245-28771246	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs137888424	chr6:28771249-28771250	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs548705248	chr6:28771255-28771256	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs142395667	chr6:28771300-28771301	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs117046150	chr6:28771320-28771321	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs9257219	chr6:28771334-28771335	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs540294687	chr6:28771347-28771348	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs35045623	chr6:28771388-28771389	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs559154006	chr6:28771396-28771397	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs368008183	chr6:28771397-28771398	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs9378149	chr6:28771414-28771415	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs199940127	chr6:28771466-28771467	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs371774198	chr6:28771480-28771481	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs552460542	chr6:28771501-28771502	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs553367329	chr6:28771502-28771503	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs574407239	chr6:28771519-28771520	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs569061234	chr6:28771531-28771532	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs531830534	chr6:28771550-28771551	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs150535118	chr6:28771585-28771586	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs189653219	chr6:28771589-28771590	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs139531019	chr6:28771600-28771601	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs182878085	chr6:28771637-28771638	Bivalent/Poised TSS Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs149710513	chr6:28771651-28771652	Bivalent/Poised TSS Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs114511453	chr6:28771684-28771685	Bivalent/Poised TSS Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs188651707	chr6:28771685-28771686	Bivalent/Poised TSS Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs572170063	chr6:28771689-28771690	Bivalent/Poised TSS Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs115616358	chr6:28771774-28771775	Bivalent/Poised TSS Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs193277699	chr6:28771807-28771808	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs113774525	chr6:28771825-28771826	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs144560141	chr6:28771826-28771827	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs540734832	chr6:28771844-28771845	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs560247116	chr6:28771845-28771846	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs187492759	chr6:28772016-28772017	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs191645246	chr6:28772064-28772065	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs562883735	chr6:28772065-28772066	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:628 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:28770200-28771600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
2	chr6:28770200-28771800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
3	chr6:28770200-28771800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
4	chr6:28770400-28770800	Active TSS	Hela-S3	cervix
5	chr6:28770400-28771200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr6:28770400-28771400	Enhancers	GM12878-XiMat	blood
7	chr6:28770400-28771600	Active TSS	H9 Cell Line	embryonic stem cell
8	chr6:28770400-28771600	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr6:28770400-28771600	Active TSS	K562	blood
10	chr6:28770400-28771800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
11	chr6:28770400-28771800	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
12	chr6:28770400-28771800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
13	chr6:28770400-28771800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
14	chr6:28770400-28771800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
15	chr6:28770400-28771800	Active TSS	A549	lung
16	chr6:28770600-28770800	Bivalent/Poised TSS	HepG2	liver
17	chr6:28770600-28770800	Enhancers	HMEC	breast
18	chr6:28770600-28771000	Active TSS	NHEK	skin
19	chr6:28770600-28771200	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr6:28770600-28771800	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr6:28770800-28771000	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
22	chr6:28770800-28771200	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr6:28770800-28771200	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr6:28770800-28771200	Active TSS	NHLF	lung
25	chr6:28770800-28771400	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr6:28770800-28771400	Bivalent/Poised TSS	Primary T killer memory cells from peripheral blood	blood
27	chr6:28770800-28771400	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr6:28770800-28771400	Flanking Active TSS	HMEC	breast
29	chr6:28770800-28771600	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
30	chr6:28770800-28771600	Flanking Bivalent TSS/Enh	HepG2	liver
31	chr6:28770800-28771800	Flanking Active TSS	Hela-S3	cervix
32	chr6:28771000-28771200	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
33	chr6:28771000-28771200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr6:28771000-28771200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr6:28771000-28771200	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
36	chr6:28771000-28771200	Bivalent Enhancer	HUVEC	blood vessel
37	chr6:28771000-28771400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
38	chr6:28771000-28771400	Flanking Active TSS	NHEK	skin
39	chr6:28771200-28771400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr6:28771200-28771400	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr6:28771200-28771400	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr6:28771200-28771400	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr6:28771200-28771400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr6:28771400-28771800	Active TSS	HMEC	breast
45	chr6:28771400-28771800	Enhancers	NHEK	skin
46	chr6:28771400-28772200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr6:28771400-28775800	Weak transcription	GM12878-XiMat	blood
48	chr6:28771600-28771800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
49	chr6:28771600-28771800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
50	chr6:28771600-28771800	Flanking Active TSS	K562	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links